Source: https://www.fortunebusinessinsights.com/biological-wastewater-treatment-market-112643
The global biological wastewater treatment market was valued at USD 10.99 billion in 2025 and is projected to grow from USD 11.67 billion in 2026 to USD 18.87 billion by 2034, exhibiting a CAGR of 6.19% during the forecast period. The market benefits from increasing environmental pressure and the expanding need for sustainable water management practices across the globe.
Biological treatment uses microorganisms to degrade organic contaminants in wastewater. These processes are energy-efficient and environmentally friendly, making them preferred across municipal, industrial, and agricultural applications. As of 2023, around 77% of European wastewater treatment facilities employed biological treatment methods, reflecting strong regional adoption of sustainable practices. In the United States, 72% of wastewater treatment plants used some form of biological process, while 49% of India's wastewater systems incorporated biological treatment methods.
Government Regulations and Industrial Growth are the primary catalysts driving market expansion. Stringent national legislation around wastewater discharges and environmental protection mandates widespread adoption of biological treatment technologies. In parallel, rapid industrial activity — particularly across Asia-Pacific — is generating unprecedented volumes of wastewater, accelerating the need for effective treatment solutions.
High Capital Costs and Skilled Workforce Shortages continue to limit broader market adoption. Small and medium-scale industries often lack the financial resources to invest in advanced biological treatment systems. Additionally, the shortage of trained personnel to operate complex biological and automation systems reduces overall operational efficiency. The variability of wastewater composition across industrial sectors further complicates the deployment of standardized solutions, necessitating costly customized approaches.
Decentralized and Modular Treatment Systems present a major growth opportunity, enabling scalability and flexibility in underserved or remote areas. These systems align well with circular economy principles, facilitating energy and nutrient recovery from wastewater to generate additional revenue streams. Rapidly developing regions such as Africa and Latin America represent large untapped markets, where demand for reliable wastewater infrastructure continues to grow.
By Process Type: The aerobic segment holds the dominant market share, driven by widespread municipal use and simpler implementation. Urbanization and expanding sewage treatment networks continue to support its leadership. The anaerobic segment, however, is forecast to register the most significant growth, particularly in industrial settings, owing to its advantages in energy recovery and reduced sludge generation from high-strength wastewater.
By End-User: The municipal segment leads the market, propelled by urbanization, government infrastructure investment, and stringent discharge regulations. The industrial segment is experiencing considerable growth across sectors such as chemicals, food & beverage, and pharmaceuticals, as companies adopt in-house treatment systems to meet regulatory and sustainability requirements.
Asia-Pacific is positioned as the fastest-growing region, driven by rapid urbanization, expanding industries, and government initiatives to modernize wastewater infrastructure — particularly in China and India.
North America maintains a strong market presence, backed by progressive environmental regulations and continuous adoption of advanced treatment technologies in both municipal and industrial systems.
Europe remains a significant contributor, with robust environmental policies, a strong focus on resource recovery and energy efficiency, and well-established circular economy frameworks supporting sustained demand.
Veolia Water Technologies (France), SUEZ (France), Aquatech (U.S.), Evoqua Water Technologies (U.S.), Xylem (U.S.), OVIVO Inc. (Canada), Ecolab (U.S.), Samco Technologies (U.S.), JSC Biotechnologijos Grupė (Lithuania), and DuPont (U.S.).
Report Period: 2021–2034 | Base Year: 2025 | Source: Fortune Business Insights